Godard Michael DO is categorized under Family Practice Doctors in Roxboro, NC and active since 2005.
Godard Michael DO was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Godard at the company’s single location by writing to 107 Weeks Drive # B, Roxboro, North Carolina NC 27573 or by phoning (336) 598-5480. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Godard Michael DO |
| Contact Person: | Michael Godard |
| Address: | 107 Weeks Drive # B, Roxboro, North Carolina 27573 |
| Phone Number: | (336) 598-5480 |
| Website Address: | roxborofamilymedicine.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Godard Michael DO was started in 2005 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Godard for inquiries that concern Godard Michael DO by calling the company number (336) 598-5480, as your correspondence is most welcome. Additionally, the physical location of the single location of Godard Michael DO can be found at the coordinates 36.3722,-78.9803 as well as the street address 107 Weeks Drive # B in Roxboro, North Carolina 27573.
For its online presence, you may visit Godard Michael DO’s website at roxborofamilymedicine.com and engage with its social media outlets through on Twitter and on Facebook.